"Thanks to new Multiplicom test kits physicians are able to identify all the genetic mutations of a condition at once, and use this information to initiate the right - personalized - treatment.”
Multiplicom nominated for the award ‘Promising Company of the Year 2016’
EY nominated Multiplicom for the award of ‘Promising Company of the Year 2016’. This title is awarded by the Flemish government to companies who show clear growth potential. The nominees are all fast-growing enterprises in a development phase.
Other nominees are e-BO Enterprises, MediaGeniX Next Generation and Restore. The winner of the award will be announced on Tuesday 18 October 2016.
Read more about this award here.
Multiplicom N.V. is a Belgian biotech company that develops, manufactures and commercializes molecular diagnostic kits that are essential to providing everyone with access to effective, affordable and personalized medicine. Multiplicom enables clinical laboratories to diagnose patients with a genetic disease or predisposition, steer cancer therapy, and identify congenital defects early in pregnancy.